As expected, CEA levels were significantly higher in CRC patients (104 ± 52 ng·mL−1) than in healthy volunteers (1.1 ± 0.1 ng·mL−1) (P < 0.0001) (Fig. 5C). This evidence concerns the gene CEACAM5 and colorectal carcinoma.